市場調査レポート

商品コード

1268539

ボツリヌス毒素の世界市場（2023年～2032年）

Global Botulinum Toxin Market Forecast 2023-2032

出版日: 2023年05月08日 | 発行: Inkwood Research

| ページ情報: 英文 233 Pages | 納期: 2～3営業日

価格

Unprintable PDF (Single User License)

USD 2,900 453,937円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

PDF (Corporate License)

USD 4,500 704,385円

レポートPDFを同一企業内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.53円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のボツリヌス毒素の市場規模は、2023年から2032年までの予測期間中のCAGRは10.07%となっています。美容施術の需要の急増、高齢者人口の増加、非侵襲的な美容施術の需要は、市場の成長を促進しています。

当レポートでは、世界のボツリヌス毒素市場について調査しており、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

市場規模・推定
市場概要
調査範囲
危機シナリオ分析
- ボツリヌス毒素市場に対するCOVID-19の影響
主な市場調査結果
- 市場の成長に貢献する有利な規制認可
- 「NOTOX」に対する意識の高まり
- コスメティック・ツーリズムの拡大がボツリヌス毒素の需要を増大

第3章市場力学

主な促進要因
- 美容処置に対する需要の急増
- 高齢者人口の増加
- 非侵襲的な美容処置に対する需要の高まり
主な抑制要因
- ボツリヌス毒素の悪影響に関する懸念
- 美容処置を支援する償還ポリシーの欠如

第4章主要な分析

主要な市場動向
ポーターのファイブフォース分析
- バイヤーの力
- サプライヤーの力
- 代替品
- 新規参入者
- 産業の競争
成長展望のマッピング
- 米国の成長展望マッピング
- ドイツの成長展望マッピング
- 中国の成長展望マッピング
- ブラジルの成長展望マッピング
市場成熟度分析
市場集中分析

第5章市場：タイプ別

A型ボツリヌス毒素
B型ボツリヌス毒素

第6章市場：ユーザー層別

女性
男性

第7章市場：用途別

医学
- 慢性片頭痛
- 筋けいれん
- 過活動膀胱
- 多汗症
- その他の医療用途
美容
- 目尻のしわ
- 額のしわ
- 眉のしわ/眉間
- 下顎角/咬筋
- その他の美容用途

第8章市場：エンドユーザー別

専門および皮膚科クリニック
病院およびクリニック
その他のエンドユーザー

第9章地域分析

北米
欧州
アジア太平洋
世界のその他の地域

第10章競合情勢

主要な戦略的展開
- 買収
- 製品の発売と開発
- パートナーシップ
- 事業拡大
企業プロファイル
- ABBVIE
- CANDELA MEDICAL
- DAEWOONG PHARMACEUTICAL CO LTD
- EVOLUS INC
- GALDERMA
- HUGEL INC
- IPSEN
- LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
- MEDYTOX INC
- MERZ PHARMA
- REVANCE THERAPEUTICS INC
- US WORLDMEDS LLC

図表

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - BOTULINUM TOXIN
TABLE 2: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES
TABLE 3: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 5: GLOBAL TYPE A BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: GLOBAL TYPE A BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 7: GLOBAL TYPE B BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: GLOBAL TYPE B BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 9: GLOBAL BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: GLOBAL BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 11: GLOBAL WOMEN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: GLOBAL WOMEN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 13: GLOBAL MEN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 14: GLOBAL MEN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 15: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 16: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 17: GLOBAL MEDICAL MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 18: GLOBAL MEDICAL MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 19: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 20: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 21: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 22: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 23: GLOBAL MUSCLE SPASM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 24: GLOBAL MUSCLE SPASM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 25: GLOBAL OVERACTIVE BLADDER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 26: GLOBAL OVERACTIVE BLADDER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 27: GLOBAL HYPERHIDROSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 28: GLOBAL HYPERHIDROSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 29: GLOBAL OTHER MEDICAL APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 30: GLOBAL OTHER MEDICAL APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 31: GLOBAL AESTHETIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 32: GLOBAL AESTHETIC MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 33: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 34: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 35: GLOBAL CROW'S FEET MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 36: GLOBAL CROW'S FEET MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 37: GLOBAL FOREHEAD LINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 38: GLOBAL FOREHEAD LINES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 39: GLOBAL FROWN LINES/GLABELLAR MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 40: GLOBAL FROWN LINES/GLABELLAR MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 41: GLOBAL SQUARE JAW/MASSETER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 42: GLOBAL SQUARE JAW/MASSETER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 43: GLOBAL OTHER AESTHETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 44: GLOBAL OTHER AESTHETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 45: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 46: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 47: GLOBAL SPECIALTY AND DERMATOLOGY CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 48: GLOBAL SPECIALTY AND DERMATOLOGY CLINICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 49: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 50: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 51: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 52: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 53: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 54: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 55: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 56: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 57: NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 58: KEY PLAYERS OPERATING IN NORTH AMERICA BOTULINUM TOXIN MARKET
TABLE 59: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 60: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 61: EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 62: KEY PLAYERS OPERATING IN EUROPE BOTULINUM TOXIN MARKET
TABLE 63: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 64: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 65: ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 66: KEY PLAYERS OPERATING IN ASIA-PACIFIC BOTULINUM TOXIN MARKET
TABLE 67: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 68: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 69: REST OF WORLD BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 70: KEY PLAYERS OPERATING IN REST OF WORLD BOTULINUM TOXIN MARKET
TABLE 71: LIST OF ACQUISITIONS
TABLE 72: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 73: LIST OF PARTNERSHIPS
TABLE 74: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES
FIGURE 4: GROWTH PROSPECT MAPPING FOR GERMANY
FIGURE 5: GROWTH PROSPECT MAPPING FOR CHINA
FIGURE 6: GROWTH PROSPECT MAPPING FOR BRAZIL
FIGURE 7: MARKET MATURITY ANALYSIS
FIGURE 8: MARKET CONCENTRATION ANALYSIS
FIGURE 9: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 10: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2032 (IN $ MILLION)
FIGURE 11: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2032 (IN $ MILLION)
FIGURE 12: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY USER DEMOGRAPHIC, IN 2022
FIGURE 13: GLOBAL BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2032 (IN $ MILLION)
FIGURE 14: GLOBAL BOTULINUM TOXIN MARKET, BY MEN, 2023-2032 (IN $ MILLION)
FIGURE 15: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
FIGURE 16: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2032 (IN $ MILLION)
FIGURE 17: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY MEDICAL, IN 2022
FIGURE 18: GLOBAL BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2032 (IN $ MILLION)
FIGURE 19: GLOBAL BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2032 (IN $ MILLION)
FIGURE 20: GLOBAL BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2032 (IN $ MILLION)
FIGURE 21: GLOBAL BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2032 (IN $ MILLION)
FIGURE 22: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 23: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2032 (IN $ MILLION)
FIGURE 24: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY AESTHETIC, IN 2022
FIGURE 25: GLOBAL BOTULINUM TOXIN MARKET, BY CROW'S FEET, 2023-2032 (IN $ MILLION)
FIGURE 26: GLOBAL BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2032 (IN $ MILLION)
FIGURE 27: GLOBAL BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2032 (IN $ MILLION)
FIGURE 28: GLOBAL BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2032 (IN $ MILLION)
FIGURE 29: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 30: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 31: GLOBAL BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2032 (IN $ MILLION)
FIGURE 32: GLOBAL BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2032 (IN $ MILLION)
FIGURE 33: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 34: NORTH AMERICA BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 35: UNITED STATES BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 36: CANADA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 37: EUROPE BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 38: UNITED KINGDOM BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 39: GERMANY BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 40: FRANCE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 41: ITALY BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 42: SPAIN BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 43: NORDIC COUNTRIES BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 44: POLAND BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 45: REST OF EUROPE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 46: ASIA-PACIFIC BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)
FIGURE 47: CHINA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 48: JAPAN BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 49: INDIA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 50: SOUTH KOREA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 51: SINGAPORE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 52: THAILAND BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 53: AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 54: REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 55: REST OF WORLD BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
FIGURE 56: LATIN AMERICA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
FIGURE 57: MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

Product Code: 38893

KEY FINDINGS

The global botulinum toxin market is predicted to record a 10.07% CAGR during the forecast period, 2023-2032. The surge in demand for aesthetic procedures, the rising geriatric population, and the demand for non-invasive cosmetic procedures driving the botulinum toxin market drive the market growth.

MARKET INSIGHTS

Botulinum toxin is a neurotoxin produced by certain Clostridium botulinum strains and is utilized for both therapeutic and cosmetic purposes. Its cosmetic form, commonly referred to as Botox by patients, is an injectable that temporarily reduces or eliminates wrinkles and fine lines on the face. The most frequently treated areas include frown lines, forehead wrinkles, and crow's feet around the eyes, but it is also used to treat other areas such as gummy smiles, lip lines, overactive jaw muscles, and thick neck bands.

Several factors, including increasing demand for aesthetic procedures, growth in non-invasive cosmetic procedures, research and development initiatives, and a rise in the geriatric population, are propelling the global market for botulinum toxin. With an increasing number of people worldwide undergoing aesthetic procedures each year, the market for botulinum toxin is expected to experience significant growth in the coming years.

REGIONAL INSIGHTS

The global botulinum toxin market analysis comprises a study of Europe, Asia-Pacific, North America, and Rest of World. North America is expected to dominate the market due to the growing R&D efforts to broaden therapeutic uses and an increase in cosmetic issues like crow's feet and medial canthal wrinkles. Additionally, factors such as disposable personal income and per capita disposable income in the United States are expected to fuel the growth of the botulinum toxin market in North America.

COMPETITIVE INSIGHTS

Market players invest in R&D, label extension, and acquisitions to enhance product offerings. Innovation, advertising, competitive strategies, and high concentration ratio increase industry rivalry.

Major market players include Medytox, Merz Pharma, Lanzhou Institute of Biological Products Co Ltd, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
- 2.4.1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
2.5. MAJOR MARKET FINDINGS
- 2.5.1. FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
- 2.5.2. GROWING AWARENESS ABOUT 'NOTOX'
- 2.5.3. INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES
- 3.1.2. RISING GERIATRIC POPULATION
- 3.1.3. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
3.2. KEY RESTRAINTS
- 3.2.1. CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
- 3.2.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
- 4.3.2. GROWTH PROSPECT MAPPING FOR GERMANY
- 4.3.3. GROWTH PROSPECT MAPPING FOR CHINA
- 4.3.4. GROWTH PROSPECT MAPPING FOR BRAZIL
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS

5. MARKET BY TYPE

5.1. TYPE A BOTULINUM TOXIN
5.2. TYPE B BOTULINUM TOXIN

6. MARKET BY USER DEMOGRAPHIC

6.1. WOMEN
6.2. MEN

7. MARKET BY APPLICATION

7.1. MEDICAL
- 7.1.1. CHRONIC MIGRAINE
- 7.1.2. MUSCLE SPASM
- 7.1.3. OVERACTIVE BLADDER
- 7.1.4. HYPERHIDROSIS
- 7.1.5. OTHER MEDICAL APPLICATIONS
7.2. AESTHETIC
- 7.2.1. CROW'S FEET
- 7.2.2. FOREHEAD LINES
- 7.2.3. FROWN LINES/GLABELLAR
- 7.2.4. SQUARE JAW/MASSETER
- 7.2.5. OTHER AESTHETIC APPLICATIONS

8. MARKET BY END-USER

8.1. SPECIALTY AND DERMATOLOGY CLINICS
8.2. HOSPITALS AND CLINICS
8.3. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
- 9.1.1. MARKET SIZE & ESTIMATES
- 9.1.2. NORTH AMERICA BOTULINUM TOXIN MARKET DRIVERS
- 9.1.3. NORTH AMERICA BOTULINUM TOXIN MARKET CHALLENGES
- 9.1.4. NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
- 9.1.5. KEY PLAYERS IN NORTH AMERICA BOTULINUM TOXIN MARKET
- 9.1.6. COUNTRY ANALYSIS
  - 9.1.6.1. UNITED STATES
  - 9.1.6.1.1. UNITED STATES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.1.6.2. CANADA
  - 9.1.6.2.1. CANADA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2. EUROPE
- 9.2.1. MARKET SIZE & ESTIMATES
- 9.2.2. EUROPE BOTULINUM TOXIN MARKET DRIVERS
- 9.2.3. EUROPE BOTULINUM TOXIN MARKET CHALLENGES
- 9.2.4. EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
- 9.2.5. KEY PLAYERS IN EUROPE BOTULINUM TOXIN MARKET
- 9.2.6. COUNTRY ANALYSIS
  - 9.2.6.1. UNITED KINGDOM
  - 9.2.6.1.1. UNITED KINGDOM BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.2.6.2. GERMANY
  - 9.2.6.2.1. GERMANY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.2.6.3. FRANCE
  - 9.2.6.3.1. FRANCE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.2.6.4. ITALY
  - 9.2.6.4.1. ITALY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.2.6.5. SPAIN
  - 9.2.6.5.1. SPAIN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.2.6.6. NORDIC COUNTRIES
  - 9.2.6.6.1. NORDIC COUNTRIES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.2.6.7. POLAND
  - 9.2.6.7.1. POLAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.2.6.8. REST OF EUROPE
  - 9.2.6.8.1. REST OF EUROPE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3. ASIA-PACIFIC
- 9.3.1. MARKET SIZE & ESTIMATES
- 9.3.2. ASIA-PACIFIC BOTULINUM TOXIN MARKET DRIVERS
- 9.3.3. ASIA-PACIFIC BOTULINUM TOXIN MARKET CHALLENGES
- 9.3.4. ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
- 9.3.5. KEY PLAYERS IN ASIA-PACIFIC BOTULINUM TOXIN MARKET
- 9.3.6. COUNTRY ANALYSIS
  - 9.3.6.1. CHINA
  - 9.3.6.1.1. CHINA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.3.6.2. JAPAN
  - 9.3.6.2.1. JAPAN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.3.6.3. INDIA
  - 9.3.6.3.1. INDIA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.3.6.4. SOUTH KOREA
  - 9.3.6.4.1. SOUTH KOREA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.3.6.5. SINGAPORE
  - 9.3.6.5.1. SINGAPORE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.3.6.6. THAILAND
  - 9.3.6.6.1. THAILAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.3.6.7. AUSTRALIA & NEW ZEALAND
  - 9.3.6.7.1. AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.3.6.8. REST OF ASIA-PACIFIC
  - 9.3.6.8.1. REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.4. REST OF WORLD
- 9.4.1. MARKET SIZE & ESTIMATES
- 9.4.2. REST OF WORLD BOTULINUM TOXIN MARKET DRIVERS
- 9.4.3. REST OF WORLD BOTULINUM TOXIN MARKET CHALLENGES
- 9.4.4. REST OF WORLD BOTULINUM TOXIN REGULATORY FRAMEWORK
- 9.4.5. KEY PLAYERS IN REST OF WORLD BOTULINUM TOXIN MARKET
- 9.4.6. REGIONAL ANALYSIS
  - 9.4.6.1. LATIN AMERICA
  - 9.4.6.1.1. LATIN AMERICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  - 9.4.6.2. MIDDLE EAST & AFRICA
  - 9.4.6.2.1. MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES

10. COMPETITIVE LANDSCAPE

10.1. KEY STRATEGIC DEVELOPMENTS
- 10.1.1. ACQUISITIONS
- 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 10.1.3. PARTNERSHIPS
- 10.1.4. BUSINESS EXPANSIONS
10.2. COMPANY PROFILES
- 10.2.1. ABBVIE
  - 10.2.1.1. COMPANY OVERVIEW
  - 10.2.1.2. PRODUCT LIST
  - 10.2.1.3. STRENGTHS & CHALLENGES
- 10.2.2. CANDELA MEDICAL
  - 10.2.2.1. COMPANY OVERVIEW
  - 10.2.2.2. PRODUCT LIST
  - 10.2.2.3. STRENGTHS & CHALLENGES
- 10.2.3. DAEWOONG PHARMACEUTICAL CO LTD
  - 10.2.3.1. COMPANY PROFILE
  - 10.2.3.2. PRODUCT LIST
  - 10.2.3.3. STRENGTHS & CHALLENGES
- 10.2.4. EVOLUS INC
  - 10.2.4.1. COMPANY OVERVIEW
  - 10.2.4.2. PRODUCT LIST
  - 10.2.4.3. STRENGTHS & CHALLENGES
- 10.2.5. GALDERMA
  - 10.2.5.1. COMPANY OVERVIEW
  - 10.2.5.2. PRODUCT LIST
  - 10.2.5.3. STRENGTHS & CHALLENGES
- 10.2.6. HUGEL INC
  - 10.2.6.1. COMPANY OVERVIEW
  - 10.2.6.2. PRODUCT LIST
  - 10.2.6.3. STRENGTHS & CHALLENGES
- 10.2.7. IPSEN
  - 10.2.7.1. COMPANY OVERVIEW
  - 10.2.7.2. PRODUCTS / SERVICES LIST
  - 10.2.7.3. STRENGTHS & CHALLENGES
- 10.2.8. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
  - 10.2.8.1. COMPANY OVERVIEW
  - 10.2.8.2. PRODUCT LIST
  - 10.2.8.3. STRENGTHS & CHALLENGES
- 10.2.9. MEDYTOX INC
  - 10.2.9.1. COMPANY OVERVIEW
  - 10.2.9.2. PRODUCT LIST
  - 10.2.9.3. STRENGTHS & CHALLENGES
- 10.2.10. MERZ PHARMA
  - 10.2.10.1. COMPANY OVERVIEW
  - 10.2.10.2. PRODUCT LIST
  - 10.2.10.3. STRENGTHS & CHALLENGES
- 10.2.11. REVANCE THERAPEUTICS INC
  - 10.2.11.1. COMPANY OVERVIEW
  - 10.2.11.2. PRODUCT LIST
- 10.2.12. US WORLDMEDS LLC
  - 10.2.12.1. COMPANY OVERVIEW
  - 10.2.12.2. PRODUCT LIST

ボツリヌス毒素の世界市場（2023年～2032年）

Global Botulinum Toxin Market Forecast 2023-2032

目次

第1章調査範囲と調査手法

第2章エグゼクティブサマリー

第3章市場力学

第4章主要な分析

第5章市場：タイプ別

第6章市場：ユーザー層別

第7章市場：用途別

第8章市場：エンドユーザー別

第9章地域分析

第10章競合情勢

LIST OF TABLES

LIST OF FIGURES

KEY FINDINGS

MARKET INSIGHTS

REGIONAL INSIGHTS

COMPETITIVE INSIGHTS

Our report offerings include:

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

2. EXECUTIVE SUMMARY

3. MARKET DYNAMICS

4. KEY ANALYTICS

5. MARKET BY TYPE

6. MARKET BY USER DEMOGRAPHIC

7. MARKET BY APPLICATION

8. MARKET BY END-USER

9. GEOGRAPHICAL ANALYSIS

10. COMPETITIVE LANDSCAPE

ボツリヌス毒素の世界市場（2023年～2032年）

Global Botulinum Toxin Market Forecast 2023-2032

目次

第1章 調査範囲と調査手法

第2章 エグゼクティブサマリー

第3章 市場力学

第4章 主要な分析

第5章 市場：タイプ別

第6章 市場：ユーザー層別

第7章 市場：用途別

第8章 市場：エンドユーザー別

第9章 地域分析

第10章 競合情勢

LIST OF TABLES

LIST OF FIGURES

KEY FINDINGS

MARKET INSIGHTS

REGIONAL INSIGHTS

COMPETITIVE INSIGHTS

Our report offerings include:

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

2. EXECUTIVE SUMMARY

3. MARKET DYNAMICS

4. KEY ANALYTICS

5. MARKET BY TYPE

6. MARKET BY USER DEMOGRAPHIC

7. MARKET BY APPLICATION

8. MARKET BY END-USER

9. GEOGRAPHICAL ANALYSIS

10. COMPETITIVE LANDSCAPE

第1章調査範囲と調査手法

第2章エグゼクティブサマリー

第3章市場力学

第4章主要な分析

第5章市場：タイプ別

第6章市場：ユーザー層別

第7章市場：用途別

第8章市場：エンドユーザー別

第9章地域分析

第10章競合情勢